| Issue |
Section |
Title |
File |
| Vol 6, No 3 (2010) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
THE ACTIVITY OF PROTEASOMES AND THEIR SUBUNIT COMPOSITION IN CANCER OF THE KIDNEY AND URINARY BLADDER |
(Rus)
|
| Vol 15, No 2 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Capabilities of preoperative targeted therapy in treatment of bone metastases in renal cancer |
(Rus)
|
| Vol 15, No 4 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Dynamic magnetic-resonance cystography in diagnosis of perivesical fat invasion in bladder cancer |
(Rus)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
(Rus)
|
| Vol 18, No 2 (2022) |
CLINICAL NOTES |
Ewing’s sarcoma of the ureter: a case report |
(Rus)
|
| Vol 18, No 1 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Clinical experience of using the radium-223 in patients with bone metastasis of castration-resistant prostate cancer |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma |
(Rus)
|
| Vol 21, No 3 (2025) |
CLINICAL NOTES |
A rare case of late progression of bladder cancer to the pubic bone without regional progression after 12 years |
(Rus)
|
| Vol 21, No 3 (2025) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Neoadjuvant combination drug therapy in treatment of patients with muscle-invasive bladder cancer |
(Rus)
|
